Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 62 Records) |
| Query Trace: Astrocytoma and IDH1[original query] |
|---|
| Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-oncology 2017 Aug . Suchorska Bogdana, Giese Armin, Biczok Annamaria, Unterrainer Marcus, Weller Michael, Drexler Mark, Bartenstein Peter, Schüller Ulrich, Tonn Jörg-Christian, Albert Nathalie |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| [Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 9 47 (9): 658-663. Liu Q Q, Yin X X, Zou Y, Yu T P, Gong J, Chen X Q, Nie L, Xu M, Zhang M N, Zhou Q, Chen |
| Cerebellar glioblastoma: a clinical series with contemporary molecular analysis. Acta neurochirurgica 2018 9 160 (11): 2237-2248. Hong Bujung, Banan Rouzbeh, Christians Arne, Nakamura Makoto, Lalk Michael, Lehmann Ulrich, Hartmann Christian, Krauss Joachim |
| Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (12): 2812-2819. Martínez-Ricarte Francisco, Mayor Regina, Martínez-Sáez Elena, Rubio-Pérez Carlota, Pineda Estela, Cordero Esteban, Cicuéndez Marta, Poca Maria A, López-Bigas Nuria, Ramon Y Cajal Santiago, Vieito María, Carles Joan, Tabernero Josep, Vivancos Ana, Gallego Soledad, Graus Francesc, Sahuquillo Juan, Seoane Jo |
| IDH1, ATRX, and BRAFV600E mutation in astrocytic tumors and their significance in patient outcome in north Indian population. Surgical neurology international 2018 9 29. Chatterjee Debajyoti, Radotra Bishan Dass, Kumar Narendra, Vasishta Rakesh Kumar, Gupta Sunil Kum |
| Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas. Oncology letters 2018 2 15 (2): 1600-1606. Sippl Christoph, Urbschat Steffi, Kim Yoo Jin, Senger Sebastian, Oertel Joachim, Ketter Ra |
| Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes. Gene 2018 11 685 85-95. Patil Vikas, Mahalingam Kulandaive |
| Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases. Brain pathology (Zurich, Switzerland) 2019 8 30 (2): 235-245. Kwon Mi Jung, Kang So Young, Cho Haeyon, Lee Jung Il, Kim Sung Tae, Suh Yeon-L |
| von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53. Brain tumor research and treatment 2019 Apr 7 (1): 33-38. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
| Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma. PeerJ 2019 7 e7414. Zhu Jin, Zhang Yu- |
| Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC cancer 2019 Oct 19 (1): 968. Brito Cheila, Azevedo Ana, Esteves Susana, Marques Ana Rita, Martins Carmo, Costa Ilda, Mafra Manuela, Bravo Marques José M, Roque Lúcia, Pojo Mar |
| Rare Cases of IDH1 Mutations in Spinal Cord Astrocytomas. Acta naturae 0 12 (2): 70-73. Konovalov N A, Asyutin D S, Shayhaev E G, Kaprovoy S V, Timonin S |
| Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients. Journal of neurosurgery 2020 2 134 (3): 733-741. Ishi Yukitomo, Yamaguchi Shigeru, Hatanaka Kanako C, Okamoto Michinari, Motegi Hiroaki, Kobayashi Hiroyuki, Terasaka Shunsuke, Houkin Kiyohi |
| Can quantifying the extent of 'high grade' features help explain prognostic variability in anaplastic astrocytoma? British journal of neurosurgery 2020 12 1-8. Goacher Edward, Mathew Ryan, Fayaye Oluwafikayo, Chakrabarty Aruna, Feltbower Richard, Loughrey Carmel, Roberts Paul, Chumas Pa |
| EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma. Oncology letters 2020 Dec 20 (6): 384. Taher Mohiuddin M, Dairi Ghida, Butt Ejaz Muhammad, Al-Quthami Khalid, Al-Khalidi Hisham, Jastania Raid A, Nageeti Tahani H, Bogari Neda M, Athar Mohammad, Al-Allaf Faisal A, Valerie Kristoff |
| Evaluation of the melting temperature of TaqMan probes as a genotyping method for IDH1, IDH2, and H3F3A in pediatric astrocytomas. Boletin medico del Hospital Infantil de Mexico 2020 11 77 (6): 303-311. Torres-Caballero Aranxa, Serrato Amarantha, López-Santaella Tayde, Ortiz Rosario, León Fernando Chico-Ponce de, González-Carranza Vicente, Torres-García Samuel, Arenas-Huertero Francisco, Hernández-Hernández Abrah |
| Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma. Global medical genetics 2021 8 8 (3): 116-122. Tunthanathip Thara, Sangkhathat Surasak, Kanjanapradit Kan |
| Molecular Characterization of "True" Low-Grade IDH-Wildtype Astrocytomas. Journal of neuropathology and experimental neurology 2021 4 80 (5): 431-435. Richardson Timothy E, Hatanpaa Kimmo J, Walker Jamie |
| Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-oncology 2021 4 23 (9): 1547-1559. Tesileanu C Mircea S, van den Bent Martin J, Sanson Marc, Wick Wolfgang, Brandes Alba A, Clement Paul M, Erridge Sara C, Vogelbaum Michael A, Nowak Anna K, Baurain Jean F, Mason Warren P, Wheeler Helen, Chinot Olivier L, Gill Sanjeev, Griffin Matthew, Rogers Leland, Taal Walter, Rudà Roberta, Weller Michael, McBain Catherine, van Linde Myra E, Sabedot Thais S, Hoogstrate Youri, von Deimling Andreas, de Heer Iris, van IJcken Wilfred F J, Brouwer Rutger W W, Aldape Kenneth, Jenkins Robert B, Dubbink Hendrikus J, Kros Johan M, Wesseling Pieter, Cheung Kin Jip, Golfinopoulos Vassilis, Baumert Brigitta G, Gorlia Thierry, Noushmehr Houtan, French Pim |
| Glutaminolysis dynamics during astrocytoma progression correlates with tumor aggressiveness. Cancer & metabolism 2021 4 9 (1): 18. Moreira Franco Yollanda E, Alves Maria Jose, Uno Miyuki, Moretti Isabele Fattori, Trombetta-Lima Marina, de Siqueira Santos Suzana, Dos Santos Ancely Ferreira, Arini Gabriel Santos, Baptista Mauricio S, Lerario Antonio Marcondes, Oba-Shinjo Sueli Mieko, Marie Suely Kazue Nagahas |
| Favorable role of IDH1/2 mutations aided with MGMT promoter gene methylation in the outcome of patients with malignant glioma. Future science OA 2021 2 7 (3): FSO663. Pandith Arshad A, Qasim Iqbal, Baba Shahid M, Koul Aabid, Zahoor Wani, Afroze Dil, Lateef Adil, Manzoor Usma, Bhat Ina A, Sanadhya Dheera, Bhat Abdul R, Ramzan Altaf U, Mohammad Fozia, Anwar Iq |
| Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion. World neurosurgery 2021 2 149 e1174-e1179. Zhu Jin, Hu Li-Bo, Zhao Ya-Peng, Zhang Yu- |
| Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity. The American journal of surgical pathology 2021 2 45 (8): 1082-1090. Eschbacher Kathryn L, Ida Cristiane M, Johnson Derek R, Alvi Mohammed A, Jenkins Sarah M, Ruff Michael W, Kerezoudis Panagiotis, Neth Bryan J, Pasion Romela M, Daniels David J, Kizilbash Sani H, Raghunathan Adit |
| The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomas. Neuro-oncology advances 2023 6 5 (1): vdad069. Meenakshi Vij, Raquel T Yokoda, Omid Rashidipour, Ivy Tran, Varshini Vasudevaraja, Matija Snuderl, Raymund L Yong, William S Cobb, Melissa Umphlett, Jamie M Walker, Nadejda M Tsankova, Timothy E Richards |
| Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
| The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment. Biologics : targets & therapy 2023 2 17 15-22. Kurdi Maher, Mulla Nasser, Katib Yousef, Alsinani Taghreed, Hakamy Sahar, Mj Addas Bassam, Malibary Husam, Halawa Taher F, S Farhan Marwa, Faizo Eyad, Baeesa Sal |
| CDKN2A Homozygous Deletion Is a Stronger Predictor of Outcome than IDH1/2-Mutation in CNS WHO Grade 4 Gliomas. Biomedicines 2024 10 12 (10): . Sang Hyuk Lee, Tae Gyu Kim, Kyeong Hwa Ryu, Seok Hyun Kim, Young Zoon K |
| A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design. Journal of neuro-oncology 2024 10 . Ethan A Wetzel, Amin I Nohman, Annie L Hsieh, David Reuss, Andreas W Unterberg, Ilker Y Eyüpoglu, Lingyang Hua, Gilbert Youssef, Patrick Y Wen, Daniel P Cahill, Christine Jungk, Tareq A Juratli, Julie J Mill |
| [PET/CT with 11C-methionine as a predictor of disease-free survival in patients with IDH1 wild type diffuse glioma]. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 2024 10 88 (5): 6-13. T Yu Skvortsova, Zh I Savintseva, A F Gurchin, R Yu Seliverst |
- Page last reviewed:Feb 1, 2024
- Content source: